CorMedix (CRMD)

• Market cap: $592M
• 1 day: -4.79%
• 5 days: -4.43%
• 1 month: 4.43%
• 3 months: 4.72%
• 6 months: -24.35%
• Year to date: -37.91%
• 1 year: -35.41%
• 5 years: 21.38%
• 10 years: -47.2%
• Sector: Healthcare
• Industry: Biotechnology

About: Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Employees: 191